Results 151 to 160 of about 830,959 (241)

Urinary Incontinence and Risk of All‐Cause Mortality: A Systematic Review and Meta‐Analysis of Observational Studies

Neurourology and Urodynamics, Volume 45, Issue 8, Page 1630-1642, November 2026.
ABSTRACT Aims Urinary incontinence (UI) is a prevalent condition among adults and imposes a substantial societal burden, yet its association with all‐cause mortality remains uncertain. This study systematically reviewed and quantified the association between UI and mortality risk.
Yanyan Zhou, Liwei Wang, Weijia Sun, Zhong Wang, Kuiqing Shao, Feng Xu, Zhan Gao   +6 more
wiley   +1 more source

Physiotherapy for Urinary Incontinence After Radical Prostatectomy: Current Evidence and Therapeutic Challenges. [PDF]

J Clin Med
Mastej-Stawarska I, Łuszczki E, Kochman MT.   +2 more
europepmc   +1 more source

Primary BPH Stromal Cell Cultures Exhibit Heightened Androgen‐Responsiveness

The Prostate, Volume 86, Issue 15, Page 1508-1517, November 2026.
ABSTRACT Background Benign prostatic hyperplasia (BPH) is the most common disease in aging males. BPH growth is androgen‐dependent, and it appears that androgens preferentially stimulate the growth of BPH as compared to normal prostate. The mechanism of preferential androgen stimulation of BPH growth is not clear.
Wei Chen, Fulu Dong, Mohammad Reza Askarpour, Laura E. Pascal, Rajiv Dhir, Uma Chandran, Bruce L. Jacobs, Donald B. DeFranco, Naoki Yoshimura, Zhou Wang   +9 more
wiley   +1 more source

Retzius-Sparing Robot-Assisted Radical Prostatectomy: Analysis of Functional and Oncological Outcomes. [PDF]

Medicina (Kaunas)
Akdeniz F, Ün S, Boylu U, Köseler A.
europepmc   +1 more source

Measuring patient disability in the peri‐operative period using the WHODAS 2.0 questionnaire: a systematic review

Anaesthesia, Volume 81, Issue 11, Page 1569-1580, November 2026.
Summary Introduction The World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0) is recommended by peri‐operative core outcome sets as a measure of disability. Despite its growing use, the effect of different surgical procedures on disability measured by WHODAS 2.0 remains poorly understood and heterogeneous reporting across studies ...
Romijn M. Boerlage, Daniël van Dartel, Jacqueline E. M. Vernooij, Nick J. Koning, Linda M. Posthuma, Cor J. Kalkman, Carine J. M. Doggen, Benedikt Preckel   +7 more
wiley   +1 more source

Health‐related quality of life and patient‐reported outcome measures in economic evaluation of urological technologies: challenges and opportunities

BJU International, Volume 138, Issue 5, Page 750-758, November 2026.
Objective To examine the role of health‐related quality of life (HRQoL) assessments and patient‐reported outcome measures (PROMs) in the economic evaluation of urological interventions, highlighting methodological challenges, and identifying areas for future development.
Mohammed El Bahnasawi, Charlotte Moss, Netty Kinsella, Kathie Alexina Wong, Mieke Van Hemelrijck   +4 more
wiley   +1 more source

Prehabilitation models in patients undergoing radical prostatectomy: A scoping review. [PDF]

PLoS One
Li Y, Chen Q, Chen H, Chen Y, Huang X, Li H.   +5 more
europepmc   +1 more source

Intravesical and Intraurethral Indocyanine Green for Structural Guidance During Robot‐Assisted Radical Prostatectomy: An Exploratory Trial [PDF]

Int J Urol
International Journal of Urology, Volume 33, Issue 10, October 2026.
Negoro H, Nitta S, Tanuma K, Shiga M, Nagumo Y, Nishiyama H.   +5 more
europepmc   +2 more sources

Cytoreductive Radical Prostatectomy in Oligometastatic Prostate Cancer and the Role of the Robotic Platform: A Narrative Review. [PDF]

Cancers (Basel)
Rivas JG, Silva PG, Silva HMFSD, Severo L, Pinheiro LC, Romo IG, Redondo-González E, González-Santander C, Sierra JM.   +8 more
europepmc   +1 more source

Evaluation of triplet therapy combined with robot‐assisted cytoreductive prostatectomy for high‐volume metastatic prostate cancer: a multicentre randomised controlled trial protocol

BJU International, Volume 138, Issue 5, Page 807-814, November 2026.
Background Prostate cancer (PCa) is the second most common cancer in men. For patients with high‐volume metastatic PCa (mPCa) who are fit for docetaxel, a triplet therapy regimen consisting of androgen deprivation therapy (ADT), chemotherapy, and an androgen receptor pathway inhibitor (ARPI) is recommended.
Xiangwei Yang, Zhuobin He, Jian Chen, Hanqi Lei, Binyuan Yan, Linze Chen, Hong Liu, Jun Pang   +7 more
wiley   +1 more source